---
schema_version: "secwatch.filing_event.v1"
accession: "0001663577-23-000065"
form_type: "8-K"
ticker: "MDNC"
cik: "0001931055"
company_name: "Medinotec Inc."
filed_at: "2023-02-08T23:59:59+00:00"
generated_at: "2026-06-19T22:04:36.924206+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Medinotec files first audited financials: $720K revenue, $289K net loss for 9 months

## Summary
- Revenue $720,339, gross profit $420,197, net loss $289,077 for nine months ended Nov 30, 2022.
- Total assets $5.09M (cash $2.85M), total liabilities $2.51M, deficit $766K, equity $2.58M.
- Audited statements filed with OTC Markets in support of OTCQX application.
- Operating cash flow negative $848K; financing generated $4.23M from stock ($3.47M) and debt ($931K).
- Basic EPS $(0.00); long-term debt $2.33M; no allowance for doubtful accounts.

## SEC filing metadata
- accession: 0001663577-23-000065
- form_type: 8-K
- ticker: MDNC
- cik: 0001931055
- company_name: Medinotec Inc.
- filed_at: 2023-02-08T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1931055/000166357723000065/0001663577-23-000065-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1931055/000166357723000065/mdin8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001663577-23-000065
- JSON: https://secwatch.observer/filing/0001663577-23-000065.json
- Plain text: https://secwatch.observer/filing/0001663577-23-000065.txt

## Key facts
- Earnings Releases
  Medinotec Inc. reported financial results for the nine months ended November 30, 2022.
  - Period: the nine months ended November 30, 2022
  - Result: reported results
  source text: On February 8, 2023, we completed an audit of our consolidated balance sheet as of November 30, 2022 the related consolidated statement of operations, changes in stockholders’ equity and cash flow for the nine months ended November 30, 2022 and the related notes (collectively referred to as the "Financial Statements").
  evidence_url: https://www.sec.gov/Archives/edgar/data/1931055/000166357723000065/0001663577-23-000065-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.